Drug Trial Radar · NCT03960788
Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate Cancer
Last checked: Nov 20, 2026Latest source record: May 23, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
50
Planned (sponsor's estimate)
Start
Jan 2, 2018
Primary completion
Jan 2, 2020
Study completion Jan 2, 2021
Sponsor
- Lead sponsor
- University of CincinnatiAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 23, 2019
Design
- Study type
- Interventional
- Phase
- Early phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this research study is to test to see if Gadoxetate Sodium is a useful contrast agent for detecting prostate cancer during magnetic resonance imaging (MRI). Gadoxetate Sodium is an FDA approved contrast agent that is currently used to detect liver cancer. Gadoxetate Sodium shows promise in identifying more aggressive prostate cancers at earlier stages. The study will also test to see if specific genes are expressed in the left over tissue samples from previous prostate fusion biopsy. The investigators hypothesize that Gadoxetate Sodium-enhanced MRI can differentiate aggressive prostate cancer and predict its early recurrence.
Conditions
- Cancer of the Prostate
- Castration-resistant Prostate Cancer
Interventions
Gadoxetate SodiumDrug
Gadoxetate Sodium is an FDA approved contrast agent to be used during magnetic resonance imaging.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Comparison of Gadoxetate Sodium to gadolinium in effectiveness of identification of prostate cancer as measured by contrast enhancement ratiosTime frame: 3 weeks from consent
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Cincinnati
Cincinnati, Ohio · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.